The near-total control ASML holds over the market for advanced lithography systems is facing a potential long-term threat, according to a recent analysis from investment bank Jefferies. The catalyst is significant U.S. government funding awarded to an ambitious domestic startup, signaling a strategic push to reduce reliance on European chipmaking technology.
U.S. Backing Fuels a Potential Competitor
A weekend report from Jefferies analyst Janardan Menon has brought attention to U.S.-based startup xLight. The company, which recently secured $150 million in U.S. state aid, is developing free-electron laser technology. This approach could potentially offer performance four times greater than ASML’s current extreme ultraviolet (EUV) lithography systems.
While Menon maintains a “Hold” rating on ASML shares, he identifies this development as a substantive long-term risk. Although xLight is not planning a prototype until 2028, the substantial financial backing from Washington is viewed as a clear signal of political intent to diversify the global supply chain and lessen technological dependence.
ASML Fortifies Its Technological Moat
In response to a shifting competitive landscape, ASML is not standing still. The Dutch firm moved to bolster its research capabilities last Friday by signing a framework agreement with the University of Groningen. The partnership aims to massively expand research into advanced materials and new flux processes, a strategic initiative designed to accelerate the development of next-generation lithography and protect the company’s technological lead.
Should investors sell immediately? Or is it worth buying Asml?
Market reaction to these contrasting narratives has been mixed. ASML’s stock has enjoyed an impressive rally, gaining over 40% since the start of the year. However, institutional investors are showing divergent strategies. Recent activity shows Invesco reduced its stake by 4.2%, while Brown Advisory increased its shareholding.
Short-Term Focus and Fundamental Questions
In the immediate term, chart analysts are watching a technical resistance zone between $1,130 and $1,140. From a fundamental perspective, the coming months will be crucial for investors to assess the viability of the emerging challenge. The key will be whether more concrete details on the feasibility of xLight’s technology come to light.
With no scheduled corporate earnings due in the coming week, the stock’s near-term direction is likely to be influenced by news flow regarding U.S. semiconductor policy and broader competitive developments within the industry.
Ad
Asml Stock: Buy or Sell?! New Asml Analysis from December 8 delivers the answer:
The latest Asml figures speak for themselves: Urgent action needed for Asml investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 8.
Asml: Buy or sell? Read more here...









